A double-blind RCT (n=40) in patients with non-Hodgkin's lymphoma receiving anthracyclines found no significant differences in echocardiographic parameters between the L-carnitine and placebo groups
p-AMPK/AMPK, LXR, and ABCA1 protein levels were decreased, and PARP-1 was increased in T2DM and T2DM + sham groups when compared with the NC control group
Smart began taking the brand-name GLP-1 Ozempic
Oral therapies, scalable manufacturing, lower-cost supply chains, and simplified distribution could expand GLP-1 adoption outside the highest-income markets
doi: 10.3389/fphar.2022.1026182 Received 23 August 2022 Accepted 23 November 2022 Published 14 December 2022 Volume 13 - 2022 Edited by Junmin Zhang, Lanzhou University, China Reviewed by Yurong Lai, Gilead, United States Mei-Hua Qu, Weifang Second Peoples Hospital, China Updates Copyright 2022 He, Feng, Guo, Zhou, Li, Zhang, Zhang, Wang, Wang, Hao, Zhang, Gao, Gu, Zhang, Li and Li
#SwisseMY #SwisseBeauty #wellnessthatshines #SwisseSupplements #SwisseAstaxanthinGlutathionePlus | Swisse Malaysia
